Abstract
Purpose Oral cyclosporin A used in addition to high-dose intravenous pulse methylprednisolone has been shown to have an adjunctive effect in reversing the rejection of liver and renal transplants. The aim of this prospective study was to evaluate the benefits and risks of this combined drug therapy in acute corneal graft rejection.
Methods Eleven patients with acute corneal graft rejection received the combined regimen of a single pulse of intravenous methylprednisolone (500 mg) and a low dose of oral cyclosporin A (to maintain a trough blood level of 100-200 µg/1).
Results At a mean follow-up of 16.5 months (range 8-22 months) from the presentation of the graft rejection, reversal of graft rejection was achieved in 10 of 11 cases (90.9%). No recurrence of graft rejection was encountered during the study period. One patient developed a duodenal ulcer, which healed after medical treatment. No other complications were encountered.
Conclusions The high efficacy and low risk of the combined regimen demonstrated in this preliminary study call for a larger-scale prospective double-masked study to confirm the value of this treatment protocol.
Similar content being viewed by others
Article PDF
References
Kervic GN, Shepherd WF . The pattern of corneal graft rejection. Cornea 1990;9:234–7.
Wilson SE, Kaufman HE . Graft failure after penetrating keratoplasty. Surv Ophthalmol 1990;34:325–56.
Khodadoust AA, Silverstein AM . Transplantation and rejection of individual cell layers of the cornea. Invest Ophthalmol 1969;8:180–95.
Smolin G, Goodman D . Corneal graft reaction. Int Ophthalmol Clin 1988;28:30–6.
Boisjoly HM, Bernard PM, Dube I, Laughrea PA, Bazin R, Bernier J . Effect of factors unrelated to tissue matching on corneal transplant endothelial rejection. Am J Ophthalmol 1989;107:647–54.
Hill JC, Maske R, Watson P . Corticosteroids in corneal graft rejection: oral versus single pulse therapy. Ophthalmology 1991;98:329–33.
Hill JC, Maske R, Watson PG . The use of a single pulse of intravenous methylprednisolone in the treatment of corneal graft rejection: a preliminary report. Eye 1991;5:420–4.
Hill JC . Corticosteroid in corneal graft rejection: double versus single pulse therapy. Cornea 1994;13:383–8.
Silverman ED, Myones BL, Miller JJ . Lymphocyte subpopulation alterations induced by intravenous megadose pulse methylprednisolone. J Rheumatol 1984;11:287–90.
Borel JF, Feurer C, Gubler HU . Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 1976;6:468–75.
Belin MW, Bouchard CS, Phillips TM . Update on topical cyclosporin A: background, immunology, and pharmacology. Cornea 1990;9:184–95.
Calne RY, Rolles K, White DJ, et al. Cyclosporin-A in clinical organ grafting. Transplant Proc 1981;13:349–58.
Starzl TE, Iwatsuki S, Klintmalm G, et al. Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc 1981;13:281–5.
Sundmacher R, Reinhard T, Heering P . Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients: a retrospective study. Ger J Ophthalmol 1992;1:432–6.
Hill JC . Systemic cyclosporin in high-risk keratoplasties: short- versus long-term therapy. Ophthalmology 1994;101:128–33.
Hill JC . The use of cyclosporin in high-risk keratoplasties. Am J Ophthalmol 1989;107:506–10.
Homan WP, Fabre JW, Millard PR, Morris PJ . Effect of cyclosporin A upon second-set rejection of rat renal allografts. Transplantation 1980;30:354–7.
Gratwohl A, Forster I, Speck B . Skin grafts in rabbits with cyclosporin A: absence of induction of tolerance and untoward side effects. Transplantation 1981;31:136–8.
Hess AD, Esa AH, Colombani PM . Mechanisms of action of cyclosporin: effect of cells of the immune system on subcellular events in T cell activation. Transplant Proc 1988;20:29–40.
Margreiter R, Huber C, Spielberger M, Konig P . Cyclosporine in the treatment of acute cadaveric kidney graft rejection refractory to high-dose methylprednisolone. Transplantation 1983;36:203–4.
Margreiter R, Lang A, Koenig P, et al. Cyclosporine in the treatment of acute allograft rejection refractory to high-dose methylprednisolone: results of a prospectively randomised trial. Transplant Proc 1984;16:1202–4.
Rolfe MW, Kunkel SL, Demeester SR, et al. Expression of interleukin-6 in association with rat lung reimplantation and allograft rejection. Am Rev Respir Dis 1993;147:1010–6.
Ford HR, Hoffman RA, Tweardy DJ, et al. Evidence that production of interleukin-6 within rejecting allograft coincides with cytotoxic T lymphocyte development. Transplantation 1991;51:656–61.
Keenan RJ, Zeevi A, Iacono AT, et al. Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics. Surgery 1995;118:385–91.
Belin MW, Bouchard CS, Frantz S, Chmielinska J . Topical cyclosporine in high-risk corneal transplants [see comments]. Ophthalmology 1989;96:1144–50.
Goichot-Bonnat EL, Pouliquen YJM . Topical cyclosporin A in high-risk keratoplasty. In: Cavanagh HD, editor. Third international congress on the cornea. New York: Raven Press, 1988:399–101.
Charnick SB, Nedelman JR, Chang CT, et al. Description of blood pressure changes in patients beginning cyclosporin A therapy. Ther Drug Monit 1997;19:17–24.
Mills RA, Jones DB, Winkler CR, Wallace GW, Wilhelmus KR . Topical FK-506 prevents experimental corneal allograft rejection. Cornea 1995;14:157–60.
Hikita N, Lopez JS, Chan CC, et al. Use of topical FK506 in a corneal graft rejection model in Lewis rats. Invest Ophthalmol Vis Sci 1997;38:901–9.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported in part by the Mrs Annie Wong Eye Foundation
Presented in part at the Hong Kong Ophthalmological Symposium, December 1996
Rights and permissions
About this article
Cite this article
Lam, D., Wong, A., Tham, C. et al. The use of combined intravenous pulse methylprednisolone and oral cyclosporin A in the treatment of corneal graft rejection: A preliminary study. Eye 12, 615–618 (1998). https://doi.org/10.1038/eye.1998.154
Issue Date:
DOI: https://doi.org/10.1038/eye.1998.154
Keywords
This article is cited by
-
Systemic cyclosporine and corneal transplantation
International Ophthalmology (2016)
-
Case–control study of subconjunctival triamcinolone acetonide injection vs intravenous methylprednisolone pulse in the treatment of endothelial corneal allograft rejection
Eye (2009)
-
Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience
Eye (2002)
-
The use of combined intravenous pulse methylprednisolone and low-dose oral cyclosporin A in the treatment of corneal graft rejection: Addendum to previous report
Eye (1999)
-
Graft rejection
Eye (1998)